42096 Federal Register / Vol. 87, No. 134 / Thursday, July 14, 2022 / Rules and Regulations 

as to persons who are not owners or 

operators of USTs 

Section 1351–B–2.0 Installation, Operation 

and Maintenance Requirements for UST 

Systems Storing Regulated Substance 

Installed Prior to January 11, 2008, 

Excluding Consumptive Use Heating Fuel 

or Hazardous Substance, except 2.1.8; 

2.22.1, 2.23.1, 2.23.2, 2.30.7.1 as to persons 

who are not owners or operators of USTs 

Section 1351–B–3.0 Change in Service 

Requirements for UST Systems Storing 

Regulated Substance Excluding 

Consumptive Use Heating Fuel or 

Hazardous Substance 

Section 1351–B–4.0 Removal or Closure in 

Place Requirements for UST Systems 

Storing Regulated Substance excluding 

Consumptive Use Heating Fuel or 

Hazardous Substance, except 4.2.1.3 

Section 1351–B–5.0 Change In Substance 

Stored Requirements for UST Systems 

Storing Regulated Substance excluding 

Consumptive Use Heating Fuel or 

Hazardous Substance, except 5.2.1.3 

Section 1351–B–6.0 Requirements for 

Empty UST Systems Storing Regulated 

Substance excluding Consumptive Use 

Heating Fuel or Hazardous Substance 

Part D: Requirements for Installation, 

Operation and Maintenance of Underground 

Storage Tank Systems Storing Hazardous 

Substance 

Section 1351–D–1.0 Installation, Operation 

and Maintenance Requirements for UST 

Systems Storing Hazardous Substance, 

except 1.3.2.4; 1.21.1, 1.22.1 and 1.22.2 as 

to persons who are not owners or operators 

of USTs 

Section 1351–D–2.0 Change In Service 

Requirements for UST Systems Storing 

Hazardous Substance 

Section 1351–D–3.0 Removal or Closure in 

Place Requirements for UST Systems 

Storing Hazardous Substance, except 

3.2.1.3 

Section 1351–D–4.0 Change In Substance 

Stored Requirements for UST Systems 

Storing Hazardous Substance, except 

4.2.1.3 

Section 1351–D–5.0 Requirements for 

Empty UST Systems Storing Hazardous 

Substance 

Part E: Requirements for Reporting, Release 

Investigation, Remedial Action and No 

Further Action Determinations for 

Underground Storage Tank Systems 

Section 1351–E–1.0 Reporting 

Requirements, except 1.2 and 1.3 as to 

persons who are not owners or operators of 

USTs 

Section 1351–E–2.0 Indicated Release 

Investigation Requirements, except 2.1, 2.2, 

and 2.4 as to persons who are not owners 

or operators of USTs; 2.3.1 and 2.4.1.1 as 

to USTs containing heating fuel for 

consumptive use on the premises where 

stored 

Section 1351–E–3.0 Release Response 

Requirements, except 3.1; 3.2 and 3.3 as to 

persons who are not owners or operators of 

USTs 

Section 1351–E–4.0 Hydrogeologic 

Investigation Requirements, except as to 

persons who are not owners or operators of 

USTs 

Section 1351–E–5.0 Remedial Action 

Requirements, except as to persons who 

are not owners or operators of USTs 

Section 1351–E–6.0 No Further Action 

Requirements, except as to persons who 

are not owners or operators of USTs; 6.2.3 

as to USTs containing heating fuel for 

consumptive use on the premises where 

stored 

Part F: Financial Responsibility 

Requirements for UST Systems 

Section 1351–F–1.0 Financial 

Responsibility Requirements for UST 

Systems 

Section 1351–F–2.0 Financial 

Responsibility Mechanisms 

Sections 1351–F–3.1 to –3.18 Forms A 

through R 

Part H: Requirements for Installation, 

Operation and Maintenance of FieldConstructed Underground Storage Tank 

Systems 

Section 1351–H–1.0 General Requirements, 

except 1.1.2.2 as to USTs containing 

heating fuel for consumptive use on the 

premises where stored 

Section 1351–H–2.0 Additions, Exceptions, 

and Alternatives for UST systems with 

Field-Constructed Tanks 

Part I: Requirements for Installation, 

Operation and Maintenance of Airport 

Hydrant Fuel Systems 

Section 1351–I–1.0 General Requirements, 

except 1.1.2.2 as to USTs containing 

heating fuel for consumptive use on the 

premises where stored 

Section 1351–I–2.0 Additions, Exceptions, 

and Alternatives for Airport Hydrant Fuel 

Systems 

(2) [Reserved] 

* * * * * 

[FR Doc. 2022–15097 Filed 7–13–22; 8:45 am] 

BILLING CODE 6560–50–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

42 CFR Part 414 

[CMS–5536–N] 

Medicare Program; MIPS Payment 

Adjustment Exception Applicable for 

Enhancing Oncology Model Monthly 

Enhanced Oncology Services (MEOS) 

Payments 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), Health and 

Human Services (HHS). 

ACTION: Payment advisory. 

SUMMARY: This advisory is to inform 

potential Enhancing Oncology Model 

(EOM) applicants and participants that 

the Merit-based Incentive Payment 

System (MIPS) payment adjustment 

factors will not apply to Monthly 

Enhanced Oncology Services (MEOS) 

payments in EOM. 

DATES: This action is effective on 

August 15, 2022. 

FOR FURTHER INFORMATION CONTACT: 

Alexandra Chong, (410) 786–8988. 

SUPPLEMENTARY INFORMATION: 

I. Background 

In the calendar year (CY) 2019 

Physician Fee Schedule (PFS) final rule 

(83 FR 59887), we finalized 

amendments to 42 CFR 414.1405(e) 

effective January 1, 2019 such that 

Merit-based Incentive Payment System 

(MIPS) payment adjustment factors 

would apply to Part B payments for 

covered professional services as defined 

in section 1848(k)(3)(A) of the Social 

Security Act (the Act). 

In the CY 2019 PFS final rule, per the 

authority in section 1115A(d)(1) of the 

Act to waive the requirement to apply 

the MIPS payment adjustment factors 

under section 1848(q)(6)(E) of the Act 

and § 414.1405(e) because the waiver is 

necessary solely for purposes of testing 

models that involve such payments, we 

also finalized an exception to 

§ 414.1405(e) at § 414.1405(f), such that 

the MIPS payment adjustment factors do 

not apply to model-specific payments 

that meet all the following conditions: 

• Are made only to participants in a 

model tested under section 1115A of the 

Act. 

• Would otherwise be subject to the 

requirement to apply the MIPS payment 

adjustment factors if the payment is 

made with respect to a MIPS eligible 

clinician participating in a section 

1115A model. 

• Either have a specified payment 

amount or are paid according to a 

methodology for calculating a modelspecific payment that is applied in a 

consistent manner to all model 

participants, such that application of the 

MIPS payment adjustment factors 

would potentially interfere with CMS’s 

ability to effectively evaluate the impact 

of the APM. 

In the CY 2019 PFS final rule, we also 

finalized that we would provide public 

notice of the applicability of this waiver 

for a particular model by: (1) updating 

the Quality Payment Program website 

(www.qpp.cms.gov) when new modelspecific payments subject to this waiver 

are announced; and (2) providing 

notification in the Federal Register to 

update the public on any new modelspecific payments to which this waiver 

will apply. 

The Enhancing Oncology Model 

(EOM) and associated Request for 


jspears on DSK121TN23PROD with RULES1
Federal Register / Vol. 87, No. 134 / Thursday, July 14, 2022 / Rules and Regulations 42097 

Application (RFA) was announced on 

[June 27, 2022]. Under EOM, which 

builds on lessons learned to date from 

the Oncology Care Model (OCM), 

participating physician practices will 

take on financial and performance 

accountability for episodes of care 

surrounding systemic chemotherapy 

administration to cancer patients who 

are EOM beneficiaries, by way of a 

potential lump-sum performance-based 

payment or performance-based 

recoupment, and will have the 

opportunity to submit claims for an 

EOM Monthly Enhanced Oncology 

Services (MEOS) payment for Enhanced 

Services furnished to EOM 

beneficiaries. EOM is a 5-year voluntary 

model tested per the authority under 

section 1115A of the Act that aims to 

improve quality and reduce costs 

through its payment methodology being 

aligned with care quality, and through 

EOM participants’ opportunities to 

redesign care and improve the quality of 

care furnished to beneficiaries receiving 

care for certain cancers, including 

requirements to implement participant 

redesign activities and to engage in 

activities that promote health equity. 

More information regarding EOM, and a 

link the EOM RFA, can be found at 

https://innovation.cms.gov/innovationmodels/enhancing-oncology-model. 

EOM will include an EOM MEOS 

payment for non-dually eligible 

beneficiaries and an EOM MEOS 

payment for dually-eligible 

beneficiaries, and each will be a per 

beneficiary per month (PBPM) payment 

under EOM only with a model-specific 

Healthcare Common Procedure Coding 

System (HCPCS) code paid through the 

Medicare fee-for-service claims system 

for the provision of Enhanced Services, 

as outlined in the section V.C.ii. of the 

EOM RFA. 

II. Applicability to EOM MEOS 

Payments 

This payment advisory serves to 

notify potential EOM applicants and 

participants that the MIPS payment 

adjustment factors will not apply to the 

EOM MEOS payments. The EOM MEOS 

payments meet the criteria described in 

§ 414.1405(f)(1) through (3) for the 

following reasons: 

• The EOM MEOS payments will 

only be made to EOM participants and 

EOM is a model tested under section 

1115A of the Act. 

• The EOM MEOS payments may be 

subject to the requirement to apply the 

MIPS payment adjustment factors as the 

EOM MEOS payments would be made 

to MIPS eligible clinicians participating 

in EOM. 

• The EOM MEOS payments will be 

one of two specified payment amounts 

that will be offered in a consistent 

manner to all EOM participants, a fixed 

PBPM payment for non-dually eligible 

beneficiaries (currently planned to be 

$70 PBPM) and a fixed PBPM payment 

for dually eligible beneficiaries 

(currently planned to be $100 PBPM), to 

support the provision of Enhanced 

Services to EOM beneficiaries. 

As such, the application of the MIPS 

payment adjustment factors to the EOM 

MEOS payments would introduce 

variation in the EOM MEOS amounts 

paid to different EOM participants 

which could potentially interfere with 

our ability to effectively evaluate the 

impact of EOM and therefore potentially 

compromise the model test. 

This waiver would begin at the 

beginning of EOM and continue for the 

duration of EOM. In addition to this 

Federal Register document, we will also 

provide public notice that 42 CFR 

414.1405(e) will not apply to the EOM 

MEOS payment on the Quality Payment 

Program website, at www.qpp.cms.gov. 

The Administrator of the Centers for 

Medicare & Medicaid Services (CMS), 

Chiquita Brooks-LaSure, having 

reviewed and approved this document, 

authorizes Trenesha Fultz-Mimms, who 

is the Federal Register Liaison, to 

electronically sign this document for 

purposes of publication in the Federal 

Register. 

Trenesha Fultz-Mimms, 

Federal Register Liaison, Centers for Medicare 

& Medicaid Services. 

[FR Doc. 2022–15062 Filed 7–13–22; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF THE INTERIOR 

Office of the Secretary 

43 CFR Part 2 

[DOI–2021–0002; DS67010000, 

DWSNF0000.XD0000, DP67012, 

22XD4523WS] 

RIN 1090–AB24 

Social Security Number Fraud 

Prevention Act of 2017 Implementation 

AGENCY: Office of the Secretary, Interior. 

ACTION: Direct final rule. 

SUMMARY: The Department of the 

Interior (DOI) is publishing a direct final 

rule to promulgate regulations to 

implement the provisions of the Social 

Security Number Fraud Prevention Act 

of 2017. The new regulations will 

prohibit the inclusion of an individual’s 

Social Security account number (SSN) 

on any document sent through the mail 

unless the Secretary of the Interior 

deems it necessary and precautions are 

taken to protect the SSN. The 

regulations also include requirements 

for the safeguarding of SSNs sent 

through the mail by partially redacting 

SSNs where feasible and prohibiting the 

display of SSNs on the outside of any 

package or envelope sent by mail. This 

rule is being published as a direct final 

rule as DOI does not expect any adverse 

comments. If adverse comments are 

received, this direct final rule will be 

withdrawn and a proposed rule for 

comments will be published. 

DATES: This rule is effective September 

12, 2022 without further action unless 

adverse comment is received by August 

15, 2022. If adverse comment is 

received, DOI will publish a timely 

withdrawal of the rule in the Federal 

Register. 

ADDRESSES: Send written comments 

identified by docket number [DOI– 

2021–0002] or [Regulatory Information 

Number (RIN) 1090–AB24], by any of 

the following methods: 

• Federal e-Rulemaking Portal: http:// 

www.regulations.gov. Follow the 

instructions for submitting comments to 

docket number [DOI–2021–0002]. 

• Email: DOI_Privacy@ios.doi.gov. 

Include docket number [DOI–2021– 

0002] or RIN 1090–AB24 in the subject 

line of the message. 

• U.S. mail or hand-delivery: Teri 

Barnett, Departmental Privacy Officer, 

U.S. Department of the Interior, 1849 C 

Street NW, Room 7112, Washington, DC 

20240. 

Instructions: All submissions received 

must include the agency name and 

docket number [DOI–2021–0002] or RIN 

1090–AB24 for this rulemaking. All 

comments received will be posted 

without change to http://

www.regulations.gov, including any 

personal information provided. 

Docket: For access to the docket to 

read background documents or 

comments received, go to http://

www.regulations.gov. 

FOR FURTHER INFORMATION CONTACT: Teri 

Barnett, Departmental Privacy Officer, 

U.S. Department of the Interior, 1849 C 

Street NW, Room 7112, Washington, DC 

20240, DOI_Privacy@ios.doi.gov or (202) 

208–1605. 

SUPPLEMENTARY INFORMATION: 

I. Background 

The Social Security Number Fraud 

Prevention Act of 2017 (the Act), Public 

Law 115–59, 42 U.S.C. 405 note, was 

signed on September 15, 2017. The Act 

restricts the inclusion of SSNs on any 

documents sent by mail unless the head 


jspears on DSK121TN23PROD with RULES1